Company: DRTSW
Filing Date: 2025-06-23
Form Type: F-3
Source: 0001213900-25-056744
Chunk: 13

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-06-23
Form: F-3
Chunk 13
---
”).                                                                                     |

The IR/PR Warrants were issued as restricted securities, were exercisable immediately upon issuance and will expire on the 2.5 year anniversary of the effective date of the Strategic Services Agreement. In addition, we agreed to register the ordinary shares issuable upon exercise of the IR/PR Warrants for resale by Oramed pursuant to this registration statement. Design-Build Agreement On June 23, 2025, we entered into an amendment to our Design-Build Agreement, dated July 22, 2024 (as amended, the “Design-Build Agreement”) with A & M Construction, whereby we engaged A & M Construction, on a non-exclusive basis, to provide us with various contracting services. Pursuant to the amendment, as partial consideration for the services under the Design-Build Agreement, we agreed to issue 226,202 of our ordinary shares to A & M Construction and to register such ordinary shares for resale pursuant to this registration statement.

<div align='center'>3</div>

Corporate Information We were founded in November 2015 and are registered with the Israeli Registrar of Companies. Our registration number is 51-534453-9. Our website address is www.alphatau.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus and is not incorporated by reference herein. We have included our website address in this prospectus solely for informational purposes. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers, such as we, that file electronically, with the SEC at www.sec.gov. The main address of our principal executive offices is Kiryat HaMada St. 5, Jerusalem, Israel 9777605 and its telephone number is +972 (3) 577-4115. Our agent for service of process in the United States is Alpha Tau Medical, Inc., 1 Union Street 3rd Floor, Lawrence, MA 01840. Implications of Being an Emerging Growth Company We are an emerging growth company, or EGC, as defined in the JOBS Act. For as long as we continue to be an EGC, we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not EGCs, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Ox